SCHEMBL8308609

SCHEMBL8308609

CCC(=NO)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.55
MAPT P10636 5/20 0.55
SMN1; SMN2 Q16637 4/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
HDAC8 Q9BY41 1/20 0.50
GAA P10253 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
HPGD P15428 2/20 0.47
ALDH1A1 P00352 4/20 0.46
MGLL Q99685 1/20 0.44
KDM4E B2RXH2 3/20 0.43
AGTR1 P30556 1/20 0.43
USP2 O75604 1/20 0.42
PTPN1 P18031 1/20 0.41
GSK3B P49841 1/20 0.41
WDR5 P61964 1/20 0.41
GRIN2B Q13224 1/20 0.41
NCOA3 Q9Y6Q9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL264821 0.87 ATM (0.71) ATMMAPTSMN1; SMN2L3MBTL1GAA
SCHEMBL2776027 0.87 ATM (0.71) ATMMAPTSMN1; SMN2L3MBTL1GAA
SCHEMBL10041972 0.87 ATM (0.71) ATMMAPTSMN1; SMN2L3MBTL1GAA
SCHEMBL28059946 0.85 ATM (0.68) ATMMAPTSMN1; SMN2L3MBTL1GAA
SCHEMBL17973385 0.79 HDAC8 (0.50) MAPTSMN1; SMN2L3MBTL1HDAC8HPGD
SCHEMBL17973366 0.78 HDAC8 (0.52) ATMMAPTSMN1; SMN2L3MBTL1HDAC8
SCHEMBL5433266 0.78 CYP1A2 (0.49) ATMSMN1; SMN2GAAMEN1KMT2A
SCHEMBL5433262 0.78 CYP1A2 (0.49) ATMSMN1; SMN2GAAMEN1KMT2A
SCHEMBL10874676 0.77 ESR1 (0.54) ATMMAPTSMN1; SMN2L3MBTL1GAA
SCHEMBL16563870 0.77 ESR1 (0.54) ATMMAPTSMN1; SMN2L3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1056840-C Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2000-09-27 CN disclosed
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
CN-1143639-A Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1997-02-26 CN disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed